Mirati Therapeutics, Inc.

CITADEL ADVISORS LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

66,611

Value ($000)

3,913

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	3,913	0.0%	66,611	12/31/2023
2023 Q3	11/14/2023	49,285	0.1%	1,131,438	9/30/2023
2023 Q2	8/14/2023	17,408	0.0%	481,818	6/30/2023
2023 Q1	5/15/2023	3,370	0.0%	90,644	3/31/2023
2022 Q4	2/14/2023	5,460	0.0%	120,503	12/31/2022
2022 Q3	11/14/2022	6,208	0.0%	88,886	9/30/2022
2022 Q2	8/15/2022	5,150	0.0%	76,720	6/30/2022
2022 Q1	5/16/2022	1,547	0.0%	18,811	3/31/2022
2021 Q4	2/14/2022	6,917	0.0%	47,149	12/31/2021
2021 Q3	11/15/2021	6,703	0.0%	37,890	9/30/2021
2021 Q2	8/16/2021	73,915	0.1%	457,597	6/30/2021
2021 Q1	5/21/2021	70,441	0.1%	411,215	3/31/2021
2020 Q4	2/16/2021	38,079	0.0%	173,373	12/31/2020
2020 Q3	11/16/2020	2,092	0.0%	12,595	9/30/2020
2020 Q2	8/14/2020	6,552	0.0%	57,382	6/30/2020
2020 Q1	5/15/2020	6,534	0.0%	84,997	3/31/2020
2019 Q4	2/14/2020	16,751	0.0%	129,993	12/31/2019